Optiva Inc. Announces Results of Annual Meeting
Detailed results of the votes are as follows:
1. Election of Directors
2. Appointment and Remuneration of Auditor
Appointment of KPMG LLP as the auditor of the Company and authorizing the Company's board of directors to fix the remuneration of the auditor.
About Optiva Inc.
Optiva Inc. is a leading provider of mission-critical, cloud-native, agentic AI-powered revenue management software for the telecommunications industry. Its products are delivered globally on the private and public cloud. The Company's solutions help service providers maximize digital, 5G, IoT and emerging market opportunities to achieve business success. Established in 1999, Optiva Inc. is listed on the Toronto Stock Exchange (TSX:OPT). For more information, visit
www.optiva.com
.
For additional information, please contact:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
17 minutes ago
- Business Wire
Investcorp Credit Management BDC, Inc. Announces Financial Results for the Quarter Ended June 30, 2025, and Quarterly and Supplemental Distribution
NEW YORK--(BUSINESS WIRE)--Investcorp Credit Management BDC, Inc. (NASDAQ: ICMB) ('ICMB' or the 'Company') announced its financial results today for its fiscal quarter ended June 30, 2025. HIGHLIGHTS On August 7, 2025, the Company's Board of Directors (the 'Board') declared a distribution of $0.12 per share for the quarter ending September 30, 2025, payable in cash on October 9, 2025, to stockholders of record as of September 18, 2025, and a supplemental distribution of $0.02 per share, payable on October 9, 2025, to stockholders of record as of September 18, 2025. During the quarter, ICMB made investments in one new portfolio company and four existing portfolio companies. These investments totaled $19.0 million, at cost. The weighted average yield (at origination) of debt investments made in the quarter was 9.03%. ICMB fully realized its investments in three portfolio companies during the quarter, totaling $9.5 million in proceeds. The internal rate of return on these investments was 32.82%. During the quarter, the Company had net advances of $2.9 million on new and existing delayed draw and revolving credit commitments to portfolio companies. The weighted average yield on debt investments, at fair market value, for the quarter ended June 30, 2025, was 10.57%, compared to 10.95% for the quarter ended March 31, 2025. Net asset value decreased $0.15 per share to $5.27, compared to $5.42 as of March 31, 2025. Net assets decreased by $2.1 million, or 2.71%, during the quarter ended June 30, 2025 compared to March 31, 2025. Portfolio results, as of and for the three months ended June 30, 2025: Total assets $224.1mm Investment portfolio, at fair value $204.1mm Net assets $76.0mm Weighted average yield on debt investments, at fair market value (1) 10.57% Net asset value per share $5.27 Portfolio activity in the current quarter: Number of investments in new portfolio companies during the period 1 Number of portfolio companies invested in, end of period 43 Total capital invested in existing portfolio companies (2) $19.0mm Total proceeds from repayments, sales, and amortization (3) $10.2mm Net investment income before taxes (NII) $0.8mm Net investment income before taxes per share $0.06 Net decrease in net assets from operations ($0.4)mm Net decrease in net assets from operations per share ($0.03) Distributions paid per common share $0.12 (1) Represents average yield on total debt investments weighted by fair market value as of June 30, 2025. The weighted average yield on total debt investments reflected above does not represent actual investment returns to the Company's stockholders. (2) Includes gross advances for delayed draw and revolving credit commitments and PIK interest to existing portfolio companies. (3) Includes gross repayments on existing delayed draw and revolving credit commitments to portfolio companies. Expand Mr. Suhail A. Shaikh said 'We continued to execute our strategy with discipline during the second quarter, generating stable net investment income and maintaining strong credit quality despite a mixed headline environment. Our origination activity picked up late in the quarter, reflecting the strength of our sponsor relationships and our commitment to a highly selective investment approach. As we look ahead, we are encouraged by early signs of momentum and remain focused on repositioning the portfolio for long-term value creation.' The Company's dividend framework provides a quarterly base dividend and may be supplemented, at the discretion of the Board, by additional dividends as determined to be available by the Company's net investment income and performance during the quarter. On August 7, 2025, the Board declared a distribution for the quarter ended September 30, 2025 of $0.12 per share payable on October 9, 2025, to stockholders of record as of September 18, 2025, and a supplemental distribution of $0.02 per share, payable on October 9, 2025, to stockholders of record as of September 18, 2025. This distribution represents a 20.07% yield on the Company's $2.79 share price as of market close on June 30, 2025. Distributions may include net investment income, capital gains and/or return of capital, however, the Company does not expect the dividend for the quarter ending June 30, 2025, to be comprised of a return of capital. The Company's investment adviser monitors available taxable earnings, including net investment income and realized capital gains, to determine if a return of capital may occur for the year. The Company estimates the source of its distributions as required by Section 19(a) of the Investment Company Act of 1940 to determine whether payment of dividends are expected to be paid from any other source other than net investment income accrued for the current period or certain cumulative periods, but the Company will not be able to determine whether any specific distribution will be treated as taxable earnings or as a return of capital until after at the end of the taxable year. Portfolio and Investment Activities During the quarter, the Company made investments in one new portfolio company and four existing portfolio companies. The aggregate capital invested during the quarter totaled $19.0 million, at cost, and the debt investments were made at a weighted average yield of 9.03%. The Company received proceeds of $10.0 million from repayments, sales and amortization during the quarter, primarily related to the realization of American Auto Auction Term Loan, 4L Technologies Term Loan, and RESA Power Equity. During the quarter, the Company had net advances of $2.9 million on new and existing delayed draw and revolving credit commitments to portfolio companies. The Company's net realized, and unrealized gains and losses accounted for a decrease in the Company's net investments of approximately $1.0 million, or $0.07 per share. The total net decrease in net assets resulting from operations for the quarter was $0.4 million, or $0.03 per share. As of June 30, 2025, the Company's investment portfolio consisted of investments in 43 portfolio companies, of which 79.23% were first lien investments and 20.77% were equity, warrants, and other investments. The Company's debt portfolio consisted of 98.50% floating rate investments and 1.50% fixed rate investments. Capital Resources As of June 30, 2025, the Company had $17.3 million in cash, of which $14.4 million was restricted cash, and $29.5 million of unused and available capacity under its revolving credit facility with Capital One, N.A. Subsequent Events Subsequent to June 30, 2025 and through August 13, 2025, the Company invested a total of $0.2 million, at cost, which included investments in two existing portfolio companies. As of August 13, 2025, the Company had investments in 43 portfolio companies. On August 7, 2025, the Board declared a distribution for the quarter ended September 30, 2025 of $0.12 per share payable on October 9, 2025 to stockholders of record as of September 18, 2025, and a supplemental distribution of $0.02 per share, payable on October 9, 2025, to stockholders of record as of September 18, 2025. On August 7, 2025, the Board authorized a new share repurchase program of up to $5 million (the "2025 Stock Repurchase Program") for a one-year period, effective August 7, 2025 and terminating on August 7, 2026. The 2025 Stock Repurchase Program may be suspended or discontinued at any time. Subject to these restrictions, the Company will selectively pursue opportunities to repurchase shares which are accretive to net asset value per share. Investcorp Credit Management BDC, Inc. and Subsidiaries Consolidated Statements of Operations (unaudited) For the three months ended June 30, For the six months ended June 30, 2025 2024 2025 2024 Investment Income: Interest income Non-controlled, non-affiliated investments $ 3,778,683 $ 4,091,556 $ 7,266,885 $ 9,652,889 Non-controlled, affiliated investments (16,912 ) (16,919 ) (1,934 ) 11,911 Total interest income 3,761,771 4,074,637 7,264,951 9,664,800 Payment in-kind interest income Non-controlled, non-affiliated investments 342,127 747,479 762,015 1,361,244 Non-controlled, affiliated investments (243 ) 20,047 21,137 39,600 Total payment-in-kind interest income 341,884 767,526 783,152 1,400,844 Dividend income Non-controlled, non-affiliated investments — — 81,607 54,138 Non-controlled, affiliated investments — — — — Total dividend income — — 81,607 54,138 Payment in-kind dividend income Non-controlled, non-affiliated investments 231,057 204,298 452,742 402,421 Non-controlled, affiliated investments — — — — Total payment-in-kind dividend income 231,057 204,298 452,742 402,421 Other fee income Non-controlled, non-affiliated investments 210,487 72,858 331,511 215,205 Non-controlled, affiliated investments — — — — Total other fee income 210,487 72,858 331,511 215,205 Total investment income 4,545,199 5,119,319 8,913,963 11,737,408 Expenses: Interest expense 1,856,195 1,956,995 3,688,162 4,131,190 Base management fees 851,734 889,715 1,699,770 1,841,514 Income-based incentive fees (118,748 ) — (118,748 ) — Professional fees 277,287 257,800 618,570 612,734 Allocation of administrative costs from Adviser 227,874 241,918 481,897 467,774 Amortization of deferred debt issuance costs 153,824 152,590 307,648 305,181 Amortization of original issue discount - 2026 Notes 17,778 17,778 35,555 35,555 Insurance expense 126,009 127,768 246,511 253,534 Directors' fees 73,500 73,500 150,000 148,657 Custodian and administrator fees 74,000 101,236 148,237 169,267 Other expenses 243,714 118,556 283,887 497,962 Total expenses 3,783,167 3,937,856 7,541,489 8,463,368 Waiver of base management fees (72,026 ) (72,899 ) (146,169 ) (170,330 ) Waiver of income-based incentive fees — — — — Net expenses 3,711,141 3,864,957 7,395,320 8,293,038 Net investment income before taxes 834,058 1,254,362 1,518,643 3,444,370 Income tax expense (benefit), including excise tax expense 229,910 (54,740 ) 310,969 56,906 Net investment income after taxes $ 604,148 $ 1,309,102 $ 1,207,674 $ 3,387,464 Net realized and unrealized gain/(loss) on investments: Net realized gain (loss) from investments Non-controlled, non-affiliated investments $ 2,208,625 $ (1,828,530 ) $ 581,343 $ (1,860,514 ) Non-controlled, affiliated investments — — — (6,239,984 ) Net realized gain (loss) from investments 2,208,625 (1,828,530 ) 581,343 (8,100,498 ) Net change in unrealized appreciation (depreciation) in value of investments Non-controlled, non-affiliated investments (2,852,187 ) 1,221,420 527,662 2,311,028 Non-controlled, affiliated investments (394,884 ) (2,654,138 ) (544,685 ) 2,861,600 Net change in unrealized appreciation (depreciation) on investments (3,247,071 ) (1,432,718 ) (17,023 ) 5,172,628 Total realized gain (loss) and change in unrealized appreciation (depreciation) on investments (1,038,446 ) (3,261,248 ) 564,320 (2,927,870 ) Net increase (decrease) in net assets resulting from operations $ (434,298 ) $ (1,952,146 ) $ 1,771,994 $ 459,594 Basic and diluted: Earnings per share $ (0.03 ) $ (0.14 ) $ 0.12 $ 0.03 Weighted average shares of common stock outstanding 14,419,405 14,401,118 14,416,218 14,399,035 Distributions declared per common share $ 0.12 $ 0.15 $ 0.24 $ 0.30 Expand About Investcorp Credit Management BDC, Inc. The Company is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940. The Company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments by targeting investment opportunities with favorable risk-adjusted returns. The Company seeks to invest primarily in middle-market companies that have annual revenues of at least $50 million and earnings before interest, taxes, depreciation, and amortization of at least $15 million. The Company's investment activities are managed by its investment adviser, CM Investment Partners LLC. To learn more about Investcorp Credit Management BDC, Inc., please visit Forward-Looking Statements Statements included in this press release and made on the earnings call for the quarter ended June 30, 2025, may contain 'forward-looking statements,' which relate to future performance, operating results, events and/or financial condition. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'will,' 'may,' 'continue,' 'believes,' 'seeks,' 'estimates,' 'would,' 'could,' 'should,' 'targets,' 'projects,' and variations of these words and similar expressions are intended to identify forward-looking statements. Any forward-looking statements, including statements other than statements of historical facts, included in this press release or made on the earnings call are based upon current expectations, are inherently uncertain, and involve a number of assumptions and substantial risks and uncertainties, many of which are difficult to predict and are generally beyond the Company's control. Investors are cautioned not to place undue reliance on these forward-looking statements. Any such statements are likely to be affected by other unknowable future events and conditions, which the Company may or may not have considered, including, without limitation, changes in base interest rates and the effects of significant market volatility on our business, our portfolio companies, our industry and the global economy. Accordingly, such statements cannot be guarantees or assurances of any aspect of future performance or events. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors and risks. More information on these risks and other potential factors that could affect actual events and the Company's performance and financial results, including important factors that could cause actual results to differ materially from plans, estimates or expectations included herein or discussed on the earnings call, is or will be included in the Company's filings with the Securities and Exchange Commission, including in the 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections of the Company's Transition Report on Form 10-KT and Quarterly Reports on Form 10-Q. All forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
Yahoo
31 minutes ago
- Yahoo
Rigetti Computing Stock Falls After Reporting ‘Lumpy' Earnings
At first glance, Rigetti Computing latest earnings report appears to be all over the place. As of June 30, the company had roughly $571.6 million in cash, cash equivalents, and available-for-sale investments, with no debt. Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA
TORONTO, ON / / August 12, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2025, with quarterly revenue growth of $349,043 to $4,346,416 ($8,897,146 YTD) and quarterly EBITDA of $627,631. The Company achieved significant growth in revenue of $349,043 or 8.73% over the prior year comparable period, with a positive EBITDA of $627,631. The increased revenue is mainly attributed to organic growth of existing clients as the Company expands its reach and services. The Company's net income and EBITDA increased by $321,597 and $251,131 respectively, compared to the same period in 2024. The Company's cash position remained strong at $2,134,132. The Company is well positioned to continue to generate free cash flow, supported by its strong recurring revenues and sales pipelines. In April, the Company secured a new major client from its sales pipeline; a milestone that marks not just a win for the Company, but a testament to the trust that the Company has built in the marketplace. Since then, the Company's I.T. and implementation teams have been hard at work, both on-site and through remote technology, in order to plan the implementation and ensure seamless onboarding experience. The dedication of the Company's implementation team has not only demonstrated its deep commitment to service but also reinforced the Company's core promise: to exceed customers' expectations by understanding their needs with precision and care. Ron Loucks, President and CEO, stated "Each success we share is the result of many hands, one mission, and a shared belief that innovation, teamwork, and integrity fuel sustainable growth. Because of our strong recurring revenues, robust sales pipelines, and exceptional team, we are well-positioned to continue building value for our clients, our people and our shareholders." About NexgenRx NexgenRx is Canada's only independent full-service Third-Party Administrator and Technology Solutions Provider, offering proprietary full front-end, eligibility, enrolment, hour bank and mobile access capabilities, together with state-of-the-art claims adjudication and full provider network coverage. These combined capabilities allow NexgenRx to provide Plan Sponsors, sophisticated administration and health benefit technology applications in a cost-effective SaaS (Software as a Service) Model. NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and plan members and deliver superior administration and claims processing solutions at a competitive cost. More information on NexgenRx can be found at Caution Regarding Forward-Looking Statements Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Although management believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The Company cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information. Forward-looking information is based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether the Company's strategies and business plans will yield the expected benefits; potential increases in sales and revenues; availability and cost of capital; the ability to identify and develop and achieve commercial success for existing and new products and technologies; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; continued development and enhancement of the Company's proprietary software technology; cyber security risks and the other risks and uncertainties disclosed in the Company's annual Management's Discussion and Analysis, as filed under the Company's profile on SEDARPLUS at Readers are cautioned that this list of risk factors should not be construed as exhaustive. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. The Company undertakes no duty to update any of the forward-looking information to conform such information to actual results or to changes in the Company's expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release. FOR FURTHER INFORMATION PLEASE CONTACT: Ronald C. LoucksNexgenRx and CEO416.695.3393 x801 Kelly Ehler CPA, CANexgenRx Financial Officer416-695-3393x803 SOURCE: NexgenRx Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
